Inhibitory effect of taurine on colonic fibrosis in rats with colitis induced by 2, 4, 6-trinitrobenzene sulphonic acid
10.3760/cma.j.issn.0254-1432.2010.01.008
- VernacularTitle:牛磺酸对三硝基苯磺酸诱导的结肠炎大鼠肠纤维化的抑制作用
- Author:
Jiafei CHENG
;
Lin LIN
;
Yueji NING
;
Wei ZHANG
;
Xueliang LI
- Publication Type:Journal Article
- Keywords:
Colitis;
Fibrosis;
Taurine;
Disease models;
animal
- From:
Chinese Journal of Digestion
2010;30(1):28-32
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of taurine on colonic fibrosis in rats with colitis induced by 2,4,6-trinitrobenzene sulphonic acid(TNBS). Methods Thirty-two SD rats were divided into normal control group, model group, low-dose (400 mg/kg) taurine group and high-dose (800 mg/kg) taurine group. Rats in normal group were administrated with 0.9% NaCl solution enema, and the other three groups received TNBS enema. The rats in low-dose and high-dose taurine groups were administrated with 400 mg/kg and 800 mg/kg of taurine daily, respectively, one week before TNBS enema. Morphology and disease activity index (DAI) were evaluated, and the colonic tissues were histologically examined. Colon length and weight of the rats were also measured. The concentrations of hydroxyproline, collagen type Ⅰ, transforming growth factor-betal(TGF-β1), and Smad3 protein and mRNA in colon tissues were tested. Results In comparison with control group, the body weight and colon length were decreased while DAI score and colon weight were increased obviously in model group (P`0.01). All above parameters were improved after intervention of taurine. The fibrotie score in model group (1.88±0.35) was significantly higher than that in control group (0.25±0.46), low-dose (1.25±0.71) and high-dose (0.75±0.47) taurine groups (all P values <0.05). High levels of hydroxyproline, collagen type Ⅰ, TGF-β1 and Smad3 were detected in model group compared with low-dose and high-dose taurine groups (all P values < 0.05). Conclusions Taurine is effective in prevention of colonic fibrosis induced by TNBS in rats, which is mediated by the down regulation of TGF-β1 and the inhibition of TGF-β/ Smad3 pathway. It may be beneficial in treatment of Crohn's disease with colonic fibrosis and strictures.
